Jenny Guilemond-Valladeau
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Melanoma cell states shape spatial tumor-immune ecosystems to dictate the efficacy of anti-PD1 immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: May 15, 2026
Type III interferon primes plasmacytoid dendritic cells for TLR7 activation to overcome TGFβ- and PGE2- mediated inhibition
Journal: Medecine sciences : M/S
Published: December 12, 2025
Dendritic cells: the central partner for cancer immunity.
Journal: Oncoimmunology
Published: November 14, 2025
HERV-derived epitopes represent new targets for T-cell-based immunotherapies in ovarian cancer.
Journal: Journal for immunotherapy of cancer
Published: July 15, 2025
IntegrAlign: a comprehensive tool for multi-immunofluorescence panel integration through image alignment.
Journal: Bioinformatics (Oxford, England)
Published: March 31, 2025
The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma.
Journal: Cancer immunology research
Published: May 07, 2024
Development of NK cell-based cancer immunotherapies through receptor engineering.
Journal: Cellular & molecular immunology
Published: November 07, 2023
Isolation and Identification of Dendritic Cell Subsets from Human and Mouse Tumors.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 11, 2023
Phenotypes and Functions of Human Dendritic Cell Subsets in the Tumor Microenvironment.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 11, 2023
Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.
Journal: Frontiers in immunology
Published: September 09, 2022
Direct T-cell Presentation by cDC1: The Key Feature for Cancer Vaccine Success?
Journal: Cancer immunology research
Published: June 10, 2022
Last Updated: 09/26/2026